Showing 3411-3420 of 5403 results for "".
Psoriasis Update: Current State, Pipeline, and More
https://practicaldermatology.com/issues/july-2025/psoriasis-update-current-state-pipeline-and-more/36509/April W. Armstrong, MD, MPH, has been a driving force behind advancements in psoriasis treatments in recent years. A professor and chief of dermatology at University of California Los Angeles, Dr. Armstrong has served in leadership positions for the National Psoriasis Foundation, International PsoriAntihistamines for Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/antihistamines-for-atopic-dermatitis/85442/In a 2026 systematic review and network meta-analysis, add-on oral antihistamines did not provide clinically meaningful improvement in atopic dermatitis disease severity or symptoms.Icotrokinra and the Oral Therapy Revolution
https://practicaldermatology.com/topics/psoriasis/icotrokinra-and-the-oral-therapy-revolution/60986/Icotrokinra is the only commercially available therapy that selectively blocks the receptor of IL-23 rather than the IL-23 cytokine.Navigating the Latest Therapeutic Options
https://practicaldermatology.com/issues/october-2025/navigating-the-latest-therapeutic-options/39762/A Q&A With Raj Chovatiya, MD, PhD, MSCI, FAADFrom SDPA: JAKs, Black Boxes, and What It All Means
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-jaks-black-boxes-and-what-it-all-means/26286/Practitioners shouldn’t fear Janus kinase (JAK) inhibitors for their patients when appropriate, according to a wide-ranging expert chat at the 2024 SDPA Annual Summer Conference in San Diego. The conversation featured Matthew Zirwas, MD, a dermatologist with DOCS Dermatology, and Amy Spizuoco, DO, FClinical Conversations Video with Dr Scott Boswell
https://practicaldermatology.com/videos/nemluvio-peer-network/clinical-conversations-video-with-dr-scott-boswell/56420/Join Dr Scott Boswell as he shares how he approaches prurigo nodularis (PN) and atopic dermatitis (AD) in his expansive dermatology practice. From his 3‑step communication framework to compelling patient stories, Dr Boswell emphasizes how prioritizing safety and understanding neuroimmune mechanismsPrioritizing Patient Comfort While Optimizing Staff Safety
https://practicaldermatology.com/columns/practice-management-essentials/prioritizing-patient-comfort-while-optimizing-staff-safety/67264/While well-intentioned, hand holding may not be practical during an ongoing procedure and could pose ergonomic concerns for the clinical team.Harnessing Psychology to Make Your Practice and Outside Life Better
https://practicaldermatology.com/topics/editorial/harnessing-psychology-make-your-practice-and-outside-life-better/26952/Harnessing Psychology to Make Your Practice and Outside Life BetterSelecting the Optimal JAK Inhibitor for Alopecia Areata
https://practicaldermatology.com/topics/hair-nails/selecting-the-optimal-jak-inhibitor-for-alopecia-areata/67265/Since 2022, the US Food and Drug Administration (FDA) has approved three oral JAK inhibitors: baricitinib, ritlecitinib, and deuruxolitinib.Best Practices for Photodynamic Therapy for Actinic Keratosis
https://practicaldermatology.com/columns/skin-cancer-essentials/best-practices-for-photodynamic-therapy-for-actinic-keratosis/67261/Photodynamic therapy (PDT) remains an effective field-directed treatment for actinic keratoses (AKs)